How to buy IRIDEX Corporation stock

IRIDEX Corporation is a medical devices business based in the US. IRIDEX Corporation shares (IRIX) are listed on the NASDAQ and all prices are listed in US Dollars. IRIDEX Corporation employs 89 staff and has a trailing 12-month revenue of around 0.00.

IRIDEX Corporation share price

Use our graph to track the performance of IRIX stocks over time.

IRIDEX Corporation shares at a glance

• Key figures

Information last updated 2021-04-30.

52-week range	$1.46 - $8.93
50-day moving average	$7.49
200-day moving average	$4.43
Wall St. target price	$9.50
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.86

Buy IRIDEX Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy IRIDEX Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of IRIDEX Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IRIDEX Corporation financials

Revenue TTM	$36.3 million
Gross profit TTM	$15.6 million
Return on assets TTM	-13.11%
Return on equity TTM	-31.59%
Profit margin	-17.41%
Book value	$1.25
Market capitalisation	$135.3 million

TTM: trailing 12 months

Shorting IRIDEX Corporation shares

There are currently 370,642 IRIDEX Corporation shares held short by investors – that's known as IRIDEX Corporation's "short interest". This figure is 0.9% down from 373,943 last month.

There are a few different ways that this level of interest in shorting IRIDEX Corporation shares can be evaluated.

IRIDEX Corporation's "short interest ratio" (SIR)

IRIDEX Corporation's "short interest ratio" (SIR) is the quantity of IRIDEX Corporation shares currently shorted divided by the average quantity of IRIDEX Corporation shares traded daily (recently around 114395.67901235). IRIDEX Corporation's SIR currently stands at 3.24. In other words for every 100,000 IRIDEX Corporation shares traded daily on the market, roughly 3240 shares are currently held short.

However IRIDEX Corporation's short interest can also be evaluated against the total number of IRIDEX Corporation shares, or, against the total number of tradable IRIDEX Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IRIDEX Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 IRIDEX Corporation shares in existence, roughly 20 shares are currently held short) or 0.024% of the tradable shares (for every 100,000 tradable IRIDEX Corporation shares, roughly 24 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against IRIDEX Corporation.

Find out more about how you can short IRIDEX Corporation stock.

IRIDEX Corporation share dividends

We're not expecting IRIDEX Corporation to pay a dividend over the next 12 months.

IRIDEX Corporation share price volatility

Over the last 12 months, IRIDEX Corporation's shares have ranged in value from as little as $1.46 up to $8.9346. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IRIDEX Corporation's is 1.1881. This would suggest that IRIDEX Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

IRIDEX Corporation overview

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc.

Frequently asked questions

• What percentage of IRIDEX Corporation is owned by insiders or institutions?

  Currently 32.483% of IRIDEX Corporation shares are held by insiders and 32.446% by institutions.

• How many people work for IRIDEX Corporation?

  Latest data suggests 89 work at IRIDEX Corporation.

• When does the fiscal year end for IRIDEX Corporation?

  IRIDEX Corporation's fiscal year ends in December.

• Where is IRIDEX Corporation based?

  IRIDEX Corporation's address is: 1212 Terra Bella Avenue, Mountain View, CA, United States, 94043

• What is IRIDEX Corporation's ISIN number?

  IRIDEX Corporation's international securities identification number is: US4626841013

• What is IRIDEX Corporation's CUSIP number?

  IRIDEX Corporation's Committee on Uniform Securities Identification Procedures number is: 462684101